• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Indivior Pharmaceuticals, Inc. - Common Stock (NQ:INDV)

32.27 +0.22 (+0.69%)
Streaming Delayed Price Updated: 4:00 PM EST, Mar 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,023,452
Open 31.52
Bid (Size) 30.50 (100)
Ask (Size) 32.60 (200)
Prev. Close 32.05
Today's Range 31.23 - 32.35
52wk Range 8.640 - 38.00
Shares Outstanding 128,000,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Divisadero Dumps Stride Stock ↗
March 06, 2026
Stride delivers technology-driven education solutions for K–12 and adult learners, serving schools, districts, and employers nationwide. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Indivior (INDV) Q4 2025 Earnings Call Transcript ↗
February 26, 2026
Indivior (INDV) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings

Performance

YTD
-9.7%
-9.7%
1 Month
-6.0%
-6.0%
3 Month
-8.1%
-8.1%
6 Month
+29.2%
+29.2%
1 Year
+226.3%
+226.3%

More News

Read More
Indivior Pharmaceuticals Inc (NASDAQ:INDV) Surpasses Q4 2025 Estimates and Provides Strong 2026 Outlook ↗
February 26, 2026
Via Chartmill
News headline image
Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results
February 26, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) Presents a High-Growth Momentum and Technical Setup Case ↗
February 20, 2026
Via Chartmill
INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) Presents a High-Growth Momentum Breakout Setup ↗
January 27, 2026
Via Chartmill
News headline image
Earnings Scheduled For October 30, 2025 ↗
October 30, 2025
Via Benzinga
News headline image
Indivior to Participate in Upcoming Investor Conferences
February 24, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Vistance Networks Stock Up 250%. Here's Why a $40 Million Position Signals a Post-Divestiture Bet ↗
February 22, 2026
Via The Motley Fool
News headline image
Array Stock Down 25%, But This $17.3 Million Buy Signals Confidence Amid Big Revenue Growth ↗
February 22, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Enviri Stock Up 120% as $43 Million Buy Makes It a Top Holding in This Portfolio ↗
February 22, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Integer Stock Down 38%, but One Fund Just Bet $40 Million on a Turnaround ↗
February 22, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26ᵗʰ
January 28, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior Announces Completion of Redomiciliation to the United States
January 26, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior Provides Full-Year 2026 Financial Guidance and Business Update
January 08, 2026
From Indivior Inc.
Via GlobeNewswire
News headline image
Mangrove Partners Loads Up Flywire With 2.9 Million Shares ↗
December 30, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
INDIVIOR PLC (NASDAQ:INDV) Presents a High-Growth Momentum and Technical Breakout Setup ↗
December 29, 2025
Via Chartmill
News headline image
This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table ↗
December 28, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Bardin Hill Dumps 349,000 Shares of Frontier Communicaitons Stock Worth $12.7 Million ↗
December 18, 2025
Via The Motley Fool
Topics Initial Public Offering Regulatory Compliance
News headline image
Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake? ↗
December 07, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stock ↗
December 07, 2025
Via The Motley Fool
News headline image
Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge ↗
December 07, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs ↗
December 07, 2025
Via The Motley Fool
News headline image
The Remitly Reassessment: What Divisadero’s 95 Million Exit Tells Us About Digital Money Movement ↗
December 03, 2025
Via The Motley Fool
News headline image
Here's Why Indivior Stock Soared 15% Today ↗
October 30, 2025
Via The Motley Fool

Frequently Asked Questions

Is Indivior Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Indivior Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Indivior Pharmaceuticals, Inc. - Common Stock trade on?
Indivior Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Indivior Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Indivior Pharmaceuticals, Inc. - Common Stock is INDV on the Nasdaq Stock Market
What is the current price of Indivior Pharmaceuticals, Inc. - Common Stock?
The current price of Indivior Pharmaceuticals, Inc. - Common Stock is 32.27
When was Indivior Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Indivior Pharmaceuticals, Inc. - Common Stock was at 03/06/26 04:00 PM ET
What is the market capitalization of Indivior Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Indivior Pharmaceuticals, Inc. - Common Stock is 4.13B
How many shares of Indivior Pharmaceuticals, Inc. - Common Stock are outstanding?
Indivior Pharmaceuticals, Inc. - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap